Last patient has completed AlzeCure's Phase Ib clinical study with NeuroRestore ACD856
AlzeCure Pharma AB, a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the last patient’s last visit (LPLV…
Read guide →